Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 14, 2015
0Patent Application Number
143124460
Date Filed
June 23, 2014
0Patent Primary Examiner
Patent abstract
Modified VEGF proteins that inhibit VEGF-mediated activation or proliferation of endothelial cells are disclosed. The analogs may be used to inhibit VEGF-mediated activation of endothelial cells in angiogenesis-associated diseases such as cancer, inflammatory diseases, eye diseases, and skin disorders.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
